Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP718845.RA4TC0WYk_dg5-tPlEm-sIr3PuE6w_TGXlexmHk5LZPd0130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP718845.RA4TC0WYk_dg5-tPlEm-sIr3PuE6w_TGXlexmHk5LZPd0130_assertion type Assertion NP718845.RA4TC0WYk_dg5-tPlEm-sIr3PuE6w_TGXlexmHk5LZPd0130_head.
- NP718845.RA4TC0WYk_dg5-tPlEm-sIr3PuE6w_TGXlexmHk5LZPd0130_assertion description "[The following percentages of these genes were found to be aberrantly methylated in gastric cancer samples; TFPI2 (80.9%), GPX3 (30.1%), DMRT1 (46.9%), GPX1 (16.7%), IGFBP6 (22.6%) and IRF7 (32.1%).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP718845.RA4TC0WYk_dg5-tPlEm-sIr3PuE6w_TGXlexmHk5LZPd0130_provenance.
- NP718845.RA4TC0WYk_dg5-tPlEm-sIr3PuE6w_TGXlexmHk5LZPd0130_assertion evidence source_evidence_literature NP718845.RA4TC0WYk_dg5-tPlEm-sIr3PuE6w_TGXlexmHk5LZPd0130_provenance.
- NP718845.RA4TC0WYk_dg5-tPlEm-sIr3PuE6w_TGXlexmHk5LZPd0130_assertion SIO_000772 19195878 NP718845.RA4TC0WYk_dg5-tPlEm-sIr3PuE6w_TGXlexmHk5LZPd0130_provenance.
- NP718845.RA4TC0WYk_dg5-tPlEm-sIr3PuE6w_TGXlexmHk5LZPd0130_assertion wasDerivedFrom befree-2016 NP718845.RA4TC0WYk_dg5-tPlEm-sIr3PuE6w_TGXlexmHk5LZPd0130_provenance.
- NP718845.RA4TC0WYk_dg5-tPlEm-sIr3PuE6w_TGXlexmHk5LZPd0130_assertion wasGeneratedBy ECO_0000203 NP718845.RA4TC0WYk_dg5-tPlEm-sIr3PuE6w_TGXlexmHk5LZPd0130_provenance.